Cancer Risks for PMS2-Associated Lynch Syndrome

  • Sanne W. ten Broeke*
  • , Heleen M. van der Klift
  • , Carli M. J. Tops
  • , Stefan Aretz
  • , Inge Bernstein
  • , Daniel D. Buchanan
  • , Albert de la Chapelle
  • , Gabriel Capella
  • , Mark Clendenning
  • , Christoph Engel
  • , Steven Gallinger
  • , Encarna Gomez Garcia
  • , Jane C. Figueiredo
  • , Robert Haile
  • , Heather L. Hampel
  • , John L. Hopper
  • , Nicoline Hoogerbrugge
  • , Magnus von Knebel Doeberitz
  • , Loic Le Marchand
  • , Tom G. W. Letteboer
    • Mark A. Jenkins, Annika Lindblom, Noralane M. Lindor, Arjen R. Mensenkamp, Pal Moller, Polly A. Newcomb, Theo A. M. van Os, Rachel Pearlman, Marta Pineda, Nils Rahner, Egbert J. W. Redeker, Maran J. W. Olderode-Berends, Christophe Rosty, Hans K. Schackert, Rodney Scott, Leigha Senter, Liesbeth Spruijt, Verena Steinke-Lange, Manon Suerink, Stephen Thibodeau, Yvonne J. Vos, Anja Wagner, Ingrid Winship, Frederik J. Hes, Hans F. A. Vasen, Juul T. Wijnen, Maartje Nielsen, Aung Ko Win
*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Cancer Risks for PMS2-Associated Lynch Syndrome'. Together they form a unique fingerprint.

Medicine and Dentistry

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology